Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Recombinant Human Adenosine Receptor A2a Protein (Fc Tag) (AC1143)
Cat.#: ACPP-1143
Specifications
Despition Recombinant Human Adenosine Receptor A2a Protein (Fc Tag) for SDS-PAGE SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence ADORA2A (Met1-Ser7) (Ser67-His Tag77) (Asn144-Pro173) (Cys259-Pro266) + hFc (Glu99-Ala330) Molecular Weight 31.7 kDa without signal peptide Purity > 95% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag C-terminal Human Fc Tag Applications SDS-PAGE Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1443 Human BSND Protein (AC1443) 2 µg inquiry ACPP-1122 Synthetic Membrane Nanoparticle Human Adenosine Receptor A2a Protein (AC1122) 50 µg inquiry ACPP-1314 Syndecan-1 Blocking Peptide (AC1314) 250 µg inquiry ACPP-1503 Human RTP4 Protein (AC1503) 5 µg inquiry ACPP-1151 Recombinant HuD Protein (AC1151) 10 µg inquiry ACPP-1247 GSK3 beta Blocking Peptide (AC1247) 250 µg inquiry ACPP-1808 Human LIF Protein, Yeast (AC1808) 5 µg inquiry ACPP-1133 Synthetic Nanodisc Human OR52D1 Protein (AC1133) 10 µg inquiry ACPP-1232 GPCR GPR15 Blocking Peptide (AC1232) 250 µg inquiry ACPP-1339 MRAP2 Blocking Peptide (AC1339) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket